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Abstract.  
Late diagnosis and high costs are key factors that negatively impact the care of 
cancer patients worldwide. Although the availability of biological markers for the 
diagnosis of cancer type is increasing, costs and reliability of tests currently 
present a barrier to the adoption of their routine use. There is a pressing need for 
accurate methods that enable early diagnosis and cover a broad range of cancers. 
The use of machine learning and RNA-seq expression analysis has shown 
promise in the classification of cancer type. However, research is inconclusive 
about which type of machine learning models are optimal. The suitability of five 
algorithms were assessed for the classification of 17 different cancer types. Each 
algorithm was fine-tuned and trained on the full array of 18,015 genes per sample, 
for 4,221 samples (75 % of the dataset). They were then tested with 1,408 samples 
(25 % of the dataset) for which cancer types were withheld to determine the 
accuracy of prediction. The results show that ensemble algorithms achieve 100% 
accuracy in the classification of 14 out of 17 types of cancer. The clustering and 
classification models, while faster than the ensembles, performed poorly due to 
the high level of noise in the dataset. When the features were reduced to a list of 
20 genes, the ensemble algorithms maintained an accuracy above 95% as opposed 
to the clustering and classification models.  
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1 Introduction 
Recent technological advances in molecular biology have resulted in cheaper and easier 
methods to perform RNA-seq expression analysis to extract the gene expression profile 
of a cell or tissue sample. These advances lead to the creation of large datasets of gene 
 expression profiles for various diseases. Given these datasets, new fields emerged 
within bioinformatics to include diagnosis of diseases using gene expression data and 
the prediction of clinical outcomes with respect to treatment. RNA-seq expression 
analysis provides a quantitative measure of the expression levels of genes in a cell. 
Current research estimates the existence of 19,000 genes per cell [1]. This data has been 
shown to contain the information necessary to diagnose cancer type.   
 
Given the vast amount of data, it is not feasible for humans to understand relationships 
between samples and genes without assistance from a machine. Machine learning and 
other types of artificial intelligence have been used to build predictive models to 
classify and understand the relationships between gene expression levels and cancer 
type [2-8]. Previous works report wide variations in either accuracy, error rates, kappa 
coefficient, specificity, sensitivity, and so on. Prior studies also performed limited 
experiments using a small number of classes, classifiers, varying number of genes, 
small datasets, and a limited number of cancer types. A wealth of data arising out of 
expansive cancer genome projects such as The Cancer Genome Atlas (TCGA) now 
exists, which can be used to train machine learning algorithms to build decision models 
to diagnose cancer type, and possibly to identify causative genetic factors. A thorough 
understanding of the strengths and weaknesses of modern classifiers is necessary in 
order to build a successful RNA-seq expression diagnostic model. This study aims to 
provide sufficient information, to highlight the best classifiers for this type of data as 
well as similarly structured datasets, and to illustrate a structured comparison of the 
performance of various machine learning algorithms.  
 
Podolsky et al. classified five cancer types using various gene expression datasets and 
found that K-nearest neighbor outperformed the support vector machine and an 
ensemble classifier [9]. Tarek et al. also found that the K-nearest neighbor achieves 
higher accuracy than ensemble methods for datasets of three types of cancer [10]. Azar 
et al. [3] and Uriarte et al. [11] showed that the Random Forest algorithm is preferable 
for gene selection using gene expression data. Al-Rajab et al. [1] and Tan and Gilbert 
[12] also highlighted the potential of using ensemble machine learning algorithms on 
gene expression data.  
 
In this study, using a much larger number of tumours, a wider range of cancer types, 
and a larger number of genes, the possibility of achieving near 100% accuracy in the 
diagnosis of cancer type is investigated along with an investigation into the 
performances of the various models. The Random Forest (RF), along with other 
ensemble machine learning algorithms such as Gradient Boosting Machine (GBM), and 
Random Ferns (RFERN) are further analyzed in this work. The performance of these 
algorithms were compared with a classification and a clustering algorithm; Support 
Vector Machine (SVM) and K-Nearest Neighbor (KNN), respectively. Preliminary 
insight is also provided regarding the most important features or the genes used by the 
most successful models in relation to cancer type. 
 
 2. Methods 
The dataset downloaded from the Catalogue of Somatic Mutations in Cancer 
(COSMIC) contained 5,629 samples with the expression levels of 18,019 genes each, 
resulting in an n × m matrix, where n = 5,629 and m = 18,019. The COSMIC data portal 
lists the gene expression dataset with the name CosmicCompleteGeneExpression.tsv. 
The version of the dataset downloaded is v80, with 101,406,435 rows in the format 
illustrated in Figure 1.  
 
 
Fig. 1. Format of the cosmic_complete_gene_expression dataset from the COSMIC repository. 
Inferring meaning from this raw dataset is difficult as the samples are not classified. 
Pre-processing is required before any machine learning models can be built. COSMIC 
also provides another dataset titled CosmicSample.tsv, which contains data on the 
primary site and the histology subtype for tumour samples as shown in Figure 2.  
 
 
Fig. 2. Layout of the cosmic_sample dataset displaying the primary site and histology subtype of 
each sample. 
Supervised machine learning models require the data to be labelled and thus, a 
combination of both datasets is needed for further analysis. The format of the processed 
 dataset used in these experiments is illustrated in Figure 3. There are 17 classes (types 
of cancer) in the dataset, ranging from 48 to 601 rows (samples).  
 
Information on how to download the data is provided on the COSMIC website located 
at URL http://cancer.sanger.ac.uk/cosmic/download. All gene expression data provided 
by COSMIC were obtained from The Cancer Genome Atlas portal, which provides 
strict guidelines on the preparation of tumour samples. According to The Cancer 
Genome Atlas, gene expression (mRNA) data for all tumours were generated by the 
University of North Carolina at Chapel Hill, Chapel Hill, N.C and all expression data 
are presented in a normalized form as z-scores [11]. All experiments were performed 
in the R environment [13] on an Asus Republic of Gamers G75V laptop with an Intel 
Core i7 2.4 GHz processor and 16 GB RAM operating on Microsoft Windows 8.1 64-
bit operating system. 
 
 
Fig. 3. Matrix representation of the pre-processed RNA-seq expression analysis, where rows 
represent samples, and columns represent the z-scores of each gene. 
RF builds classification trees are using a bootstrap sample of the dataset [6, 14, 15]. 
Each split is derived by searching a random subset (chosen by varying split points) of 
the given variables (16,718 genes) as the candidate set [16]. Although memory 
intensive, all trees are grown using all of the features in the training set to attain low-
bias trees. Many deep uncorrelated trees are also grown to ensure low variance. This 
reduced bias and variance results in a low error rate. When classifying a sample, all 
trees in the forest output a vote declaring whether or not the new sample belongs to its 
class. The random forest classifies the new sample using the highest voted class. This 
ensemble is not prone to over-fitting since splitting points are randomly chosen (there 
will always be a random distribution). Another ensemble algorithm is the GBM. GBM 
is a nonparametric machine learning approach for classification based on sequentially 
adding weak learners to the ensemble [15, 17]. GBM reduces the error in its model by 
repeatedly combining weak predictors. One new weak learner is added to the ensemble 
with the sole purpose of complementing the existing weak learners in the model. If the 
new learner does not complement the ensemble, it is discarded. This process accounts 
for the usually slow training process of a GBM.  
 
 RFERN can be considered a constrained decision tree ensemble initially created for 
image processing tasks [18]. It is somewhat similar to a binary decision tree where all 
splitting criteria are identical making it a semi-naïve bayes classifier. The ensemble is 
built by randomly choosing different subsets of features for each fern. The SVM used 
a one-versus-rest technique where each class was separated into groups whereby it is 
positive compared to all other classes [19-21]. It finds hyper-planes that maximally 
separates classes. Due to the high dimensionality of the data, attributes are projected 
onto a high dimensional plane which make the data less likely to be linearly separable. 
This technique is known to perform poorly on high dimensional data. The KNN 
algorithm plots all attributes as points in a complex dimensional space (the number of 
genes). Using Manhattan distance, this algorithm classifies a new sample based on the 
votes of the nearest neighbors [21, 22]. KNN also performs poorly when tasked with 
classifying high dimensional data. Initial clusters fail to adapt to the training data. 
Attributes which were clustered incorrectly cannot be relocated at the end of modelling. 
Feature selections methods are commonly paired with SVM and KNN to avoid these 
issues.  
3. Results and Discussion 
The full dataset contained 5,629 samples comprised of 17 classes. The classes were 
unevenly distributed with the smallest class consisting of 48 samples, compared to the 
largest class of 601 samples. There were also NA, or NULL values for some attributes 
(genes) of various classes. The full dataset contained a total of 18,015 attributes, 
however, these were filtered to remove any NA or NULL values, resulting in 16,718 
attributes per sample in the training set. After the models were built, they were then 
assessed with the task of classifying all samples in the test set, with the full 18,015 
genes. Previous works focused on reducing the number of genes in training the 
prediction models [8, 11, 23, 24]. Feature reduction is performed after analysis of the 
results of utilizing the entire genome (or a larger number of genes than previously 
studied) when building prediction models. The dataset has the peculiar characteristic of 
having the number of attributes, orders of magnitude higher than the number of 
samples. High dimensional data often contains a high level of noise which is evident in 
the performance of some models.  
 
Initially, each machine learning algorithm built its prediction model by examining a 
training set of gene expression data for which all 17 cancer types were visible. Models 
were built by finding relationships between the levels of expression of subsets of genes 
to a cancer type. The models were then assessed with a test set of gene expression data 
for which cancer types were withheld. Each algorithm was fine-tuned and trained on 
the full array of 18,015 genes per sample, for 4,221 samples (75 % of the dataset). They 
were then tested with 1,408 samples (25 % of the dataset). Table 1 shows the training 
and testing times for all models.  
 Table 1. Training and testing times of all models. 
 
 RF GBM RFERN SVM KNN 
Average training 
time (s) 
 15,859 21,445 1,332 3,271 1,524 
Testing time (s)  441 294 338 749 411 
 
 
Table 2 decomposes the overall classification accuracy by providing the accuracy for 
each class in the test set. The time taken for RF to be trained is 15,859 seconds. 
Although this is the second slowest algorithm, it attained the highest accuracy (99.89%) 
as shown in Table 2. The time taken to meticulously sift through the noise in the dataset 
lead to an overall better model. GBM accurately classified 99.68% of samples in the 
test set. These results imply that greedy boosting can be a suitable direction in 
modelling gene expression data. RFERN classified 94.12% of test samples. It achieved 
the third best accuracy with the fastest training time of 1,332 seconds. This model was 
trained faster than RF and GBM because training time grows linearly with fern size, 
rather than exponentially with tree depth (as seen with the other ensemble techniques).  
 
There is a strong correlation between training times and prediction accuracy. The 
ensemble machine learning methods are all trained differently, with GBM and RF 
requiring the most time. Whereas the classification and clustering algorithms built their 
models relatively quickly. Ensemble algorithms outperformed SVM and KNN due to 
the nature of the problem. The number of genes per sample is much greater than the 
number of samples. There are 16,718 genes per sample, however, not all of these genes 
help differentiate between various cancer types. Ensemble algorithms are built to sift 
through the noise in large datasets to extract the core features.  
Table 2. Accuracy of all models. 
Primary Site 
Histology Subtype 
RF GBM RFERN SVM KNN 
Accuracy (%) 
Central Nervous 
System Astrocytoma 
Grade IV 
100 100 100 16.67 64.29 
Cervix  
Squamous cell 
Carcinoma 
100 100 96.09 37.34 44.58 
Endometrium  100 100 98.25 0.00 5.56 
 Carcinosarcoma 
Malignant Mesodermal 
Mixed Tumour 
Endometrium  
Endometrioid 
Carcinoma 
100 100 80.92 72.86 78.57 
Haematopoietic and 
Lymphoid Tissue  
Acute Myeloid 
Leukaemia 
100 100 100 43.75 97.92 
Haematopoietic and 
Lymphoid Tissue  
Diffuse Large B cell 
Lymphoma 
97.92 97.92 95.83 0.00 45.45 
Kidney  
Chromophobe Renal 
cell Carcinoma 
100 100 100 0.00 86.96 
Kidney  
Clear cell Renal cell 
Carcinoma 
100 100 99.81 80.80 98.40 
Large Intestine  
Adenocarcinoma 
100 99.17 81.53 73.83 70.47 
Liver  
Hepatocellular 
Carcinoma 
100 100 100 54.12 95.29 
Lung  100 100 96.13 69.57 78.26 
 Adenocarcinoma 
Lung  
Squamous cell 
Carcinoma 
99.80 100 95.02 76.03 
 
76.03 
Ovary 
Serous Carcinoma 
100 100 99.25 95.59 13.24 
Pancreas  
Ductal Carcinoma 
100 100 92.26 9.38 81.25 
Prostate  
Adenocarcinoma 
100 100 89.96 82.79 95.90 
Stomach  
Adenocarcinoma 
98.60 95.79 82.11 19.40 55.22 
Upper Aerodigestive 
Tract  
Squamous cell 
Carcinoma 
100 100 92.91 69.85 
 
86.02 
Average 99.89 99.68 94.12 47.18 75.43 
 
The tumours belonging to the classes (cancer primary sites and histology subtypes): 
Central Nervous System Astrocytoma Grade IV, Cervix Squamous cell Carcinoma, 
Endometrium Carcinosarcoma Malignant Mesodermal Mixed tumour, Endometrium 
Endometrioid Carcinoma, Haematopoietic and Lymphoid Tissue Acute Myeloid 
Leukaemia, Kidney Chromophobe Renal cell Carcinoma, Kidney Clear cell Renal cell 
Carcinoma, Large Intestine Adenocarcinoma, Liver Hepatocellular Carcinoma, Lung 
Adenocarcinoma, Lung Squamous cell Carcinoma, Ovary Serous Carcinoma, Pancreas 
Ductal Carcinoma, Prostate Adenocarcinoma, and Upper Aerodigestive Tract 
Squamous cell Carcinoma were all classified with 100% accuracy by one of the 
ensemble algorithms. This implies that the genetic mutations which instigate the 
formation of these types of tumours share a similar distribution throughout all samples.  
 
Given the stellar performances of RF and GBM, features were reduced based on a 
combination of the important variables selected by both ensembles. The top 80 genes 
were extracted and these were used to train the models again. This process was repeated 
 for 60, 40, 20, and finally, 10 genes. Figure 4 illustrates the classification accuracy of 
all models built on these subsets of genes.  
 
Fig. 4. Model accuracy based on a reduction of features. 
 
The accuracy dips when the feature count is 20. These 20 genes were extracted and 
displayed in Table 3. Defensin Beta, Interferon, and Keratin Associated Proteins are 
known to be strong cancer driver genes [25, 26]. Actin and Ribonuclease has been 
shown to play a significant role in some cancer types [27]. Further work is needed to 
determine the impact of olfactory genes on cancer as the current research is conflicted 
[28, 29].  
Table 3. RF-GBM feature selection output. 
Name Description 
ACTL9 Actin Like 9 
ACTRT2 Actin Related Protein T2 
C10orf122 Testis 
C17orf105 Chromosome 17 
CLRN2 Clarin 
DEFB104A Defensin Beta 
DEFB112 Defensin Beta 
DEFB119 Defensin Beta 
DEFB136 Defensin Beta 
HS3ST3B1 Heparan Sulfate-Glucosamine 
IFNA7 Interferon 
KRTAP10.8 Keratin Associated Protein 
KRTAP19.5 Keratin Associated Protein 
KRTAP19.6 Keratin Associated Protein 
KRTAP24.1 Keratin Associated Protein 
OR10G9 Olfactory Receptor Family 
OR2M2 Olfactory Receptor Family 
OR52E4 Olfactory Receptor Family 
OR5A2 Olfactory Receptor Family 
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Many tests and statistics were analyzed to ensure integrity of the results. The high levels 
of accuracy achieved are unlikely to be due to batch bias. The Cancer Genome Atlas 
gene expression values were generated by laboratory analysis at a single source, 
therefore errors in the equipment which were used for RNA-seq expression analysis 
would have been consistent throughout the dataset. Also, all expression values were 
normalized by conversion to z-scores. There is one major limitation to this study which 
arises from the data. There are no healthy samples in the dataset. Although the ensemble 
algorithms performed well at identifying cancer type, we are still unsure of their ability 
to identify healthy or non-cancerous tumours. 
4. Conclusion 
 
The use of machine learning in cancer diagnosis is becoming more feasible as 
algorithms become less prone to error and noise, and as the volume of training data 
increases. Using machine learning and data from RNA-seq expression, the potential 
exists for faster and more accurate diagnosis of cancer type. When trained with data 
derived from RNA-seq expression analysis, the random forest and gradient boosting 
machine were able to classify cancer type with an accuracy significantly greater than 
that of a support vector machine and K-nearest neighbors. The random forest and the 
gradient boosting machine were capable of diagnosing 17 types of cancer with 
accuracies of 99.89% and 99.68%, respectively. The random ferns algorithm was the 
third best performing algorithm with an accuracy of 94.12%. It was also the fastest 
algorithm. The support vector machine and the K-nearest neighbor algorithms 
classified cancer type with 47.18% and 75.13% accuracy, respectively. This difference 
in performance is attributed to the given task and the features of the dataset. RNA-seq 
expression produces a quantitative description of the levels of expression of genes in a 
cell. There are 18,015 genes and 5,629 samples in the dataset. The number of features 
(genes) is orders of magnitude higher than the number of samples, hence there is a high 
level of noise through which these algorithms need to sift. Pairing feature selection with 
all models lead to a significant improvement in the accuracy of the support vector 
machine, and K-nearest neighbors to 71.52% and 94.74%, respectively. Defensin beta, 
keratin associated protein, and the olfactory receptor family were found to be highly 
influential in the classification of cancer type. 
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